cp wire

CP Wire Articles

Bayer’s Regorafenib is the First Drug in Innovative Global Glioblastoma Platform Trial
  • GBM AGILE is backed by more than 150 collaborators around the world
  • GBM treatment options and patient outcomes have remained largely unchanged over several decades and there is no... read more
Wed, 11/14/18 - 09:36 am
Bicycle Therapeutics Named Best New Drug Developer at World ADC Awards
  • Bicycle Therapeutics currently has 5 oncology candidates in development
  • The company also has development projects underway outside of the oncology arena


Bicycle... read more

Wed, 11/14/18 - 09:18 am
Ribometrix Pulls In $30 Million in Series A Round

Ribometrix, a biotechnology company developing small molecule therapeutics that directly target RNA to treat human diseases, announced on 11/13/18 that it has completed a $30 million Series A... read more

Wed, 11/14/18 - 12:13 am
CymaBay Therapeutics Reports Positive Results from Ph II Study of Seladelpar in Patients with Primary Biliary Cholangitis
  • At 52 weeks, the mean decreases in alkaline phosphatase were -47% and -46% in the 5/10 and 10 mg groups
  • After 26 weeks, the median changes in the pruritus visual analog scale (VAS)... read more
Tue, 11/13/18 - 10:02 am
FDA Grants Breakthrough Therapy Designation to First Oral Drug for Suicidal Bipolar Depression
  • Bipolar disorder affects 5.7 million people in the US alone
  • NRX-101 was previously granted fast track status


NeuroRx, announced on 11/13/18 that it has been granted... read more

Tue, 11/13/18 - 09:01 am

Pages